Covered recipient · General Payments record
HELEN ANAEDO
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$8,630.34
- Reported across 119 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,176.92 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $442.88 | 6 |
| Novo Nordisk AS | $253.24 | 8 |
| DEXCOM, INC. | $191.28 | 5 |
| Amgen Inc. | $149.19 | 2 |
| Medtronic, Inc. | $73.12 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $28.69 | 1 |
| Ascensia Diabetes Care US Inc. | $24.07 | 1 |
| Xeris Pharmaceuticals, Inc. | $14.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $125.00 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124878746 | CMS |
| Abbott Laboratories | $133.96 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124878748 | CMS |
| Abbott Laboratories | $22.38 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124878750 | CMS |
| Abbott Laboratories | $130.04 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124878756 | CMS |
| Abbott Laboratories | $15.75 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124878752 | CMS |
| Abbott Laboratories | $15.75 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124878754 | CMS |
| Amgen Inc. | $121.83 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111516865 | CMS |
| Amgen Inc. | $27.36 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111516867 | CMS |
| Ascensia Diabetes Care Us Inc. | $24.07 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089093577 | CMS |
| Dexcom, Inc. | $23.38 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153303487 | CMS |
| Dexcom, Inc. | $23.61 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153303489 | CMS |
| Dexcom, Inc. | $5.62 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153303491 | CMS |
| Dexcom, Inc. | $23.58 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153303493 | CMS |
| Dexcom, Inc. | $115.09 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153303495 | CMS |
| Medtronic, Inc. | $73.12 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117092842 | CMS |
| Novartis Pharmaceuticals Corporation | $28.69 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086781901 | CMS |
| Novo Nordisk Inc | $24.90 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096761002 | CMS |
| Novo Nordisk Inc | $25.00 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097235711 | CMS |
| Novo Nordisk Inc | $113.58 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097521639 | CMS |
| Novo Nordisk Inc | $5.43 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096746507 | CMS |
| Novo Nordisk Inc | $9.80 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097810295 | CMS |
| Novo Nordisk Inc | $33.14 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096990675 | CMS |
| Novo Nordisk Inc | $11.43 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096600691 | CMS |
| Novo Nordisk Inc | $29.96 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096606761 | CMS |
| Xeris Pharmaceuticals, Inc. | $14.45 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144596340 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.